<code id='F3CF88C542'></code><style id='F3CF88C542'></style>
    • <acronym id='F3CF88C542'></acronym>
      <center id='F3CF88C542'><center id='F3CF88C542'><tfoot id='F3CF88C542'></tfoot></center><abbr id='F3CF88C542'><dir id='F3CF88C542'><tfoot id='F3CF88C542'></tfoot><noframes id='F3CF88C542'>

    • <optgroup id='F3CF88C542'><strike id='F3CF88C542'><sup id='F3CF88C542'></sup></strike><code id='F3CF88C542'></code></optgroup>
        1. <b id='F3CF88C542'><label id='F3CF88C542'><select id='F3CF88C542'><dt id='F3CF88C542'><span id='F3CF88C542'></span></dt></select></label></b><u id='F3CF88C542'></u>
          <i id='F3CF88C542'><strike id='F3CF88C542'><tt id='F3CF88C542'><pre id='F3CF88C542'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:5
          Calling Bullshit course University of Washington
          Screenshot via callingbullshit.org

          Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

          Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

          advertisement

          The class website and colorful syllabus went online last month and almost instantly went viral.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          Bernie brings in new pharma CEOs to talk drug prices
          Bernie brings in new pharma CEOs to talk drug prices

          Sen.BernieSanders(I-Vt.)Moneymaker/GettyImagesYou’rereadingthewebeditionofD.C.Diagnosis,STAT’stwice-

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          AstraZeneca stays mum on Medicare drug pricing negotiations

          AstraZenecaCEOPascalSoriotJacquelynMartin/APLONDON—Medicare’sfirst-everdrugpricingnegotiationsareoff